HopeStage
Back to all studies
RecruitingNCT07585006

Vaping preferences and behavior with nicotine and similar compounds

About this titleRead the official source — NCT07585006
Medication studyAges 21+United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: from 21 years.

Listed locations
ColumbusSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 29, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
70
Sponsor
Ohio State University Comprehensive Cancer Center
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug, OTHER, PROCEDURE
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 21 Years
Official registry ID
NCT07585006
Official title
Show the full official title

Comparative Evaluation of Nicotine Analogs

Recruitment & locations

Currently recruiting

Columbus

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ohio State University Comprehensive Cancer Center, a university.

Does this study involve medication?

Yes. The study involves medication, including Nicotine, 6-Methyl Nicotine and nicotinamide.

Who can participate?

Listed age limits: from 21 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies